Crohn's Disease: The Complete Guide to Medical Management

ISBN-13: 9781556429446 / Angielski / Twarda / 2011 / 496 str.

G. Lichtenstein; Gary R. Lichtenstein

Opis

Crohn's Disease: The Complete Guide to Medical Management serves as the definitive source for medical management of Crohn's Disease (CD).

Dr. Gary R. Lichtenstein, along with Dr. Ellen J. Scherl, have collaborated with over 60 experts from around the world to provide gastroenterologists and those in training with the necessary information to successfully manage the patient with Crohn's disease.

Sections Include:
- General
o The role of the FDA in drug development; pediatric considerations; disease modifiers; and more
- Medications
o Antibiotic use in treatment of CD; oral budesonide; infliximab; novel biological and non biologic therapies for CD; and more
- Specific Clinical Scenarios
o Management of steroid unresponsive CD; management of enteric fistulae; use of pre- and probiotics; medical management of short bowel syndrome; maintenance therapy of CD; and more

Features:
- Color images, graphs, and tables
- Extensive index that includes cross-referencing to Ulcerative Colitis: The Complete Guide to Medical Management
- An appendix on Infliximab treatment
- Comprehensive references at the end of each chapter

Organized into an easy-to-reference format, Crohn's Disease: The Complete Guide to Medical Management threads theory into practice and provides Gastroenterology professionals with the most comprehensive information available on this disease state.

The other side of inflammatory bowel disease is covered in Drs. Gary R. Lichtenstein and Ellen J. Scherl's Ulcerative Colitis: The Complete Guide to Medical Management. All gastroenterologists will find both books to be essential for future practice in the treatment and care of their patients with either Crohn's disease or ulcerative colitis, as well as in the overall management of those with inflammatory bowel disease.

Spis treści

 

Dedication

Acknowledgments

About the Editor and Associate Editor

Contributing Authors

Introduction

 

Prologue           Historical Perspective of Crohn’s Disease

                           Wojciech Blonski, MD, PhD; David Kotlyar, MD; Ming V. Lin, MD; and Gary R. Lichtenstein, MD, FACP,                                            FACG, AGAF

 

Section I     General

Chapter 1         The Natural History of Inflammatory Bowel Disease

                           Pietro G. Andres, MD and Lawrence S. Friedman, MD

Chapter 2         Clinical Research in Inflammatory Bowel Disease: Placebo Response in Clinical Trials

                           Chinyu Su, MD and James D. Lewis, MD, MSCE

Chapter 3         The Role of the FDA in Drug Development in Inflammatory Bowel Disease

                           Alan C. Moss, MD and Adam Cheifetz, MD

Chapter 4         Utility of Animal Models for the Study and Treatment of Inflammatory Bowel Disease

                           Ashish Chawla, MD and Kenneth Simpson, BVM&S, PhD

Chapter 5         Pediatric Considerations in Medical Therapy in Patients With Inflammatory Bowel Disease

                           Louis R. Ghanem, MD, PhD and Robert N. Baldassano, MD

Chapter 6         The Limitations of Applying Evidence-Based Medicine to Inflammatory Bowel Disease:

                           What We Do Not Learn From Clinical Trials

                           Joshua R. Korzenik, MD and Corey A. Siegel, MD

Chapter 7         Disease Modifiers in Inflammatory Bowel Disease

                           Jaime A. Oviedo, MD and Francis A. Farraye, MD, MSc, FACP, FACG

Chapter 8         Fertility and Pregnancy in Inflammatory Bowel Disease

                           Jeffry A. Katz, MD and Vinita Elizabeth Jacob, MD

Chapter 9         Medication Adherence in Inflammatory Bowel Disease

                           Sunanda Kane, MD, MSPH, FACG, FACP, AGAF

Section II    Medications

Chapter 10       Mesalamine for Maintenance Therapy in Ulcerative Colitis: How Much, How Long?

                           Miles P. Sparrow, MD, MBBS, FRACP; Wee-Chian Lim, MD, MBBS, MMed, MRCP;
                           and Stephen B. Hanauer, MD

Chapter 11       Antibiotic Use in the Treatment of Crohn’s Disease

                           Manuel Mendizabal, MD; Wojciech Blonski, MD, PhD; David Kotlyar, MD; and Gary R. Lichtenstein, MD,             FACP, FACG, AGAF

Chapter 12       Corticosteroids in Crohn’s Disease

                           Lene Riis, MD and Pia Munkholm, MD, DMSCi

Chapter 13       Oral Budesonide for Inflammatory Bowel Disease

                           Gordon R. Greenberg, MD, FRCP(C)

Chapter 14       6-Mercaptopurine and Azathioprine in Crohn’s Disease

                           Mark T. Osterman, MD and Gary R. Lichtenstein, MD, FACP, FACG, AGAF

Chapter 15       Methotrexate in the Treatment of Crohn’s Disease

                           Ellen J. Scherl, MD, FACP, AGAF; Arun Swaminath, MD; Ryan Urquhart Warren, MD;
                           and Harrison Lakehomer, BA

Chapter 16       Calcineurin Inhibitors (Cyclosporine A, Tacrolimus, and Sirolimus) and Mycophenolate

                           Mofetil in Crohn’s Disease

                           Gerassimos J. Mantzaris, MD, PhD, AGAF

Chapter 17       Infliximab in Crohn’s Disease

                           Lawrence W. Comerford, MD and Stephen J. Bickston, MD, AGAF

Chapter 18       Anti-TNFa Therapy From Symptoms to Molecules:

                           Impact of Individual Variability on Anti-TNFa Optimization Strategies

                           Ellen J. Scherl, MD, FACP, AGAF

 

Chapter 19       Novel Biological Therapies for Crohn’s Disease

                           Iris Dotan, MD and Daniel Rachmilewitz, MD

Chapter 20       Novel Nonbiologic Therapy for Crohn’s Disease

                           Masayuki Fukata, MD, PhD and Maria T. Abreu, MD

Section III Specific Clinical Scenarios

Chapter 21       Assessment of Disease Activity in Crohn’s Disease

                           Alain Bitton, MD, FRCP(C)

Chapter 22       General Principles of Medical Therapy of Crohn’s Disease

                           Denis Franchimont, MD, PhD and Gary Wild, MD

Chapter 23       Medical Management of Severe Crohn’s Disease

                           Themistocles Dassopoulos, MD and Theodore M. Bayless, MD

Chapter 24       Medical Management of Enteric Fistulae in Crohn’s Disease

                           Mamoon Raza, MD and Charles N. Bernstein, MD

Chapter 25       Management of Refractory Crohn’s Disease

                           Herbert Tilg, MD and Arthur Kaser, MD

Chapter 26       Medical Management of Postoperative Recurrence of Crohn’s Disease

                           Geert D’Haens MD, PhD and David N. Moskovitz, MD, FRCP(C)

Chapter 27       Management of Steroid-Unresponsive Crohn’s Disease

                           Sarathchandra I. Reddy, MD, MPH and Robert Burakoff, MD, MPH, FACG, FACP

Chapter 28       Pre- and Probiotics in Crohn’s Disease

                           Robert M. Penner, BSc, MD, FRCP(C), MSc; Karen L. Madsen, PhD; and
                           Richard N. Fedorak, MD, FRCP(C)

Chapter 29       Management of Crohn’s Disease in the Ileal-Pouch Anal Anastomosis

                           Gilaad G. Kaplan MD, FRCP(C) and Remo Panaccione MD, FRCP(C)

Chapter 30       Dietary Manipulations: Enteral Therapy for Crohn’s Disease

                           Alan L. Buchman, MD, MSPH

Chapter 31       Dietary Manipulations: Parenteral Therapy for Crohn’s Disease

                           Alan L. Buchman, MD, MSPH

Chapter 32       Gastroduodenal/Proximal Crohn’s Disease

                           Ellen J. Scherl, MD, FACP, AGAF; Brian P. Bosworth, MD; Felice Schnoll-Sussman, MD;
                           Douglas M. Weine, MD; and Peter H. R. Green, MD

Chapter 33       Medical Management of Perianal Fistula

                           Tarun Misra, MD, FRCP(C) and Richard N. Fedorak, MD, FRCP(C)

Chapter 34       Medical Therapy of Diarrhea Following Bowel Resection

                           Henry J. Binder, MD

Chapter 35       Short Bowel Syndrome

                           Jane E. Onken, MD, MHS

Chapter 36       Medical Management of the Patient With an Ostomy

                           Aaron Brzezinski, MD, FRCP(C)

Chapter 37       Maintenance Therapy of Crohn’s Disease

                           Wojciech Blonski, MD, PhD; Faten Aberra, MD, MSCE; and Gary R. Lichtenstein, MD, FACP,
                           FACG, AGAF

Appendix          Infliximab Treatment

 

Financial Disclosures

 

Index